Could a security clearance, federal job, or professional license be affected by psychedelic use?

Last reviewed: August 29, 2026 · Psychedelic law changes quickly — verify current status before relying on this page.

For federal employees, federal contractors, active duty military, reservists, and others who hold or are seeking a federal security clearance, and for licensed professionals who want to understand how psychedelic use interacts with federal employment eligibility and professional license requirements.

The short answer

Yes — psychedelic use can affect a federal security clearance, federal employment eligibility, and in some cases a professional license. The mechanism differs by context. For security clearances, the concern is drug involvement with a Schedule I controlled substance — psilocybin’s federal status does not change because Oregon or Colorado authorized it under state law. For federal employment, the federal Drug-Free Workplace Act prohibits use of illegal drugs by federal employees whether on or off duty, and psilocybin is an illegal drug under federal law regardless of state authorization. For professional licenses, most state boards have not issued formal guidance on how accessing a state-licensed psilocybin program affects licensure, but specific contexts — particularly boards with federal funding conditions or military affiliation — carry additional layers. The safest approach in every category is to understand the specific framework that governs your situation before accessing psychedelic services, not after.

Federal security clearances

How clearances are adjudicated

Security clearances are adjudicated under the Adjudicative Guidelines for Determining Eligibility for Access to Classified Information (also known as the National Security Adjudicative Guidelines, or NSAG), which were revised in 2017 and apply across executive branch agencies. Guideline H covers drug involvement. The central concern is whether a person’s drug involvement — including use, possession, or association with illegal drug activity — creates doubt about their judgment, reliability, or trustworthiness.

Psilocybin is a Schedule I controlled substance under federal law. Use of psilocybin — including through Oregon’s or Colorado’s state-licensed programs — is use of an illegal drug under federal law, regardless of state authorization. The NSAG do not carve out state-authorized use. A person who discloses psilocybin use on an SF-86 is disclosing use of a Schedule I controlled substance.

What the SF-86 asks

The SF-86 (Questionnaire for National Security Positions) asks about illegal drug use within the past seven years, including whether the applicant has “used, possessed, supplied, manufactured, or sold” any controlled substance not prescribed by a licensed physician. The question references federal controlled substance law — not state law. An applicant who accessed Oregon’s licensed psilocybin program and answers this question honestly must disclose that use.

The NSAG permit adjudicators to consider mitigating factors. A single instance of psilocybin use through a state-licensed wellness program, with no pattern of drug involvement, no misuse of other substances, and candid disclosure, is a different profile from a pattern of illegal drug use. Mitigating factors include: the conduct was not recent; the conduct was an isolated incident; the individual has not used drugs since; the individual’s drug involvement is unlikely to recur; and the individual made a good-faith effort to minimize the risk of their involvement. None of these factors guarantee a favorable adjudication — but they are relevant and are evaluated.

The most significant clearance risk from a single psilocybin access event may not be the use itself but dishonest disclosure. An adjudicator who discovers undisclosed psilocybin use is more likely to sustain an adverse finding based on lack of candor — Guideline E — than one who evaluates a fully disclosed and contextualized single use event. Honesty in the SF-86 process is both ethically required and practically protective.

Ongoing clearance holders

A current clearance holder who accesses Oregon’s licensed psilocybin program and does not disclose it at the next renewal or periodic reinvestigation has withheld material information. The failure to disclose creates Guideline E (personal conduct — dishonesty) exposure that is separate from and potentially more serious than the underlying drug involvement. A clearance holder who is uncertain about their disclosure obligations should consult a security clearance attorney before accessing psilocybin services, not after.

Facilitator work and clearances

A person who holds a security clearance and obtains an OPS facilitator license — professionally participating in Oregon’s state-licensed psilocybin program as a facilitator — is in a distinct position from one who accesses the program as a client. Facilitator work does not typically involve personally consuming psilocybin. Whether professional participation in a program involving a Schedule I substance implicates Guideline H or other adjudicative criteria has not been definitively addressed in published adjudication decisions specific to OPS facilitators as of early 2026. A cleared professional considering facilitator work should consult a security clearance attorney before proceeding.

Federal employment

The federal Drug-Free Workplace Act

The Drug-Free Workplace Act of 1988 (41 U.S.C. § 8101 et seq.) requires federal agencies to establish drug-free workplace programs and prohibits federal employees from using illegal drugs on or off duty. Psilocybin is an illegal drug under federal law. A federal employee who accesses Oregon’s licensed psilocybin program has used a federally illegal substance regardless of Oregon’s state authorization. The Act’s prohibition is not limited to use that impairs work performance — it covers off-duty use of Schedule I substances.

Federal agencies implement the Act through agency-specific drug-free workplace policies. Consequences for violation depend on the agency, the position, and the circumstances — they can range from mandatory referral to an Employee Assistance Program to termination. For positions designated as Testing Designated Positions (TDPs), additional random and for-cause testing obligations apply. A federal employee who is uncertain whether their position is a TDP should confirm with their agency HR.

Federal contractors

Federal contractors who receive contracts above specified thresholds are subject to the Drug-Free Workplace Act’s contractor provisions. Contractors must establish drug-free workplace policies and require employees engaged in performance of the federal contract to notify the contractor of any criminal drug conviction. A contractor employee who uses psilocybin may not be in violation of a criminal law — accessing Oregon’s program is not a crime under Oregon law — but may be in violation of their employer’s federally required drug-free workplace policy if that policy covers federally illegal substances.

Active duty military and reservists

Active duty military personnel are subject to the Uniform Code of Military Justice (UCMJ) and Department of Defense drug policies, which prohibit use of controlled substances regardless of state law. Use of psilocybin by active duty personnel is a UCMJ violation. Reservists are subject to DoD drug policies during periods of active service and may be subject to their branch’s standards during drill weekends and other duty periods. A reservist who is not on active duty during a psilocybin access event is in a more ambiguous position — but the safest approach is to consult with a military attorney before proceeding.

VA healthcare employees

VA employees are federal employees subject to the full federal Drug-Free Workplace Act framework. As addressed in What healthcare professionals risk when participating in or recommending psychedelics, VA employees who consider facilitator work or personal psilocybin access face federal employment consequences that Oregon’s HB 2387 cannot reach.

Professional licenses with federal funding conditions

Most state professional licensing boards do not receive federal funding in a way that triggers federal drug-free workplace conditions. A state-licensed Oregon physician, therapist, or engineer whose board is not federally funded faces a state-law licensing analysis, not a federal employment analysis. For those professionals, the relevant framework is their board’s specific conduct and fitness standards — which, as described throughout Section VII, are mostly unsettled as to licensed psilocybin access.

The exception is professionals whose licenses are tied to positions that themselves carry federal conditions — a physician at a VA hospital, a counselor at a federally funded treatment program, a nurse at a federally qualified health center. Those professionals face the federal employment analysis through their employment relationship, not through their professional license itself.

The state law protection that does not reach federal contexts

HB 2387’s board discipline protection and ORS 676.190’s health professional board protection operate only against state-law consequences. Neither affects federal security clearance adjudication, federal employment obligations, or DoD drug policies. It is also worth being precise about what Oregon does not provide: there is no Oregon employment protection for off-duty psilocybin use, so a professional facing a federal problem has no state employment shield to carry into it. A professional who is protected from Oregon board discipline under HB 2387 may simultaneously face federal employment consequences that Oregon law cannot reach, and may be exposed to discharge by a private Oregon employer as well. These are parallel frameworks, and a person can be protected under one while exposed under the others.

Practical guidance

A federal employee, federal contractor, clearance holder, or active duty military member who is considering accessing psilocybin services should take the following steps before proceeding.

Review the specific federal policies that govern their position — agency drug-free workplace policy, TDP designation, contract drug-free requirements, or applicable military regulations. These are usually available from agency HR or through counsel.

Consult a security clearance attorney or federal employment attorney who can evaluate the specific situation, the SF-86 disclosure question, and the likely adjudicative implications of a candid disclosure. The cost of a consultation is low compared to the cost of a clearance loss.

Consider the timing relative to upcoming renewals, reinvestigations, or fitness evaluations. A clearance holder who has a periodic reinvestigation scheduled within the next year faces a different calculus than one whose last investigation was recent.

For reservists and National Guard members, consult with a JAG attorney or civilian military law attorney about how branch-specific drug policies apply during and between periods of duty.

When public information may be enough

The National Security Adjudicative Guidelines are publicly available at dni.gov. The SF-86 form is available at opm.gov. The Drug-Free Workplace Act provisions for federal agencies (41 U.S.C. § 8101) and federal contractors (41 U.S.C. § 8102) are at uscode.house.gov. DoD Instruction 1010.04 (Problematic Substance Use by DoD Personnel) governs military drug policy and is at health.mil.

When you should speak with a lawyer

Any person who holds a federal security clearance, works in a federal position, or is subject to DoD drug policies should consult a security clearance attorney or federal employment attorney before accessing psilocybin services. This is a category where the stakes of an adverse outcome — clearance revocation, termination from federal employment, UCMJ action — are high enough that a consultation before the fact is strongly warranted rather than optional.

You might also want to read

This article is for general informational purposes only and does not constitute legal advice. Security clearance adjudication standards, federal employment policies, and military regulations change. For advice specific to your situation, consult a licensed attorney with experience in federal security clearance and employment law.